Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Gender differences in non-motor symptoms in early, drug naïve Parkinson’s disease

    Gender differences in brain structure and function may lead to differences in the clinical expression of neurological diseases, including Parkinson’s disease (PD). Few studies reported gender-related differenc...

    Marina Picillo, Marianna Amboni, Roberto Erro, Katia Longo in Journal of Neurology (2013)

  2. No Access

    Article

    Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease

    Much pre-clinical evidence show that insulin-like growth factor 1 (IGF-1) provides protection against loss of dopaminergic neurons. Recently, IGF-1 has been proposed as a possible biomarker for early diagnosis...

    Marina Picillo, Roberto Erro, Gabriella Santangelo in Journal of Neurology (2013)

  3. No Access

    Article

    Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients

    Epidermal growth factor (EGF) has been proposed as a candidate biomarker for cognitive impairment in Parkinson’s disease (PD). We aimed to assess the relationship between serum EGF and cognitive functions in e...

    Maria Teresa Pellecchia, Gabriella Santangelo, Marina Picillo in Journal of Neurology (2013)

Page of 2 next disabled